Vertebrobasilar Dissecting Aneurysm
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged =18 years and =75 years; 2. Patients with a clinical diagnosis of "unruptured VBDAs"; 3. Patients with a baseline mRS score of 0; 4. Volunteering to participate in the study and signing the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Non-VBDAs (mainly bifurcation saccular aneurysms); 2. Patients with a combination of other serious systemic diseases at the time of diagnosis, with an expected survival time of less than 1 year; 3. Patients with other serious disease at diagnosis that would significantly interfere with follow-up; 4. Patients with symptoms related to the target aneurysm at the time of diagnosis, with an mRS score of =1; 5. Patients with other intracranial aneurysms; 6. CT/MRI showing intracranial hemorrhage or SAH (SWI microhemorrhage ignored); 7. Patients with severe allergy to gadolinium agents (rash ignored); 8. Patients with known dementia or psychiatric disorders and claustrophobia who are unable to complete the MRI and follow-up; 9. Patients who are participating in clinical trials of other drugs or devices.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neurological function score;Perioperative complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of complete occlusion of aneurysms at follow-up;Aneurysm size at follow-up; | — |
Countries
China
Contacts
Beijing Tiantan Hospital, Capital Medical University